Enter Title

April 4-7, 2019
The Diplomat Beach Resort
3555 S Ocean Drive
Hollywood, FL 33019

2019 Gold Medal Recipient

Debra L. Monticciolo, MD, FACR, FSBI, of Temple, Texas was named the 2019 Gold Medal recipient at the SBI Fellows Meeting in Chicago, which took place during the recent Radiological Society of North America (RSNA) Annual Meeting. The Gold Medal Award recognizes individuals who have made outstanding contributions to the field of breast imaging and for distinguished service to SBI and other medical societies and organizations.

Dr. Monticciolo is a board-certified radiologist with fellowship training in breast imaging. She earned her medical degree from Wayne State University in Detroit, trained in radiology at Michael Reese Medical Center in Chicago, and completed her breast imaging fellowship at the University of California, San Francisco. She is a fellow of the American College of Radiology (ACR) and the Society of Breast Imaging.

Dr. Monticciolo is a past president of SBI and recently served on the ACR Board of Chancellors as Chair of the Commission on Breast Imaging. She has also served as Chair of the Commission on Quality and Safety for ACR, which oversees all accreditation programs, practice guidelines, and technical standards nationally. Dr. Monticciolo has served two terms on the FDA’s National Mammography Quality Assurance Advisory Committee, which advises Congress on mammography quality issues, served as Chair of the American Board of Radiology’s first Final Certifying/MOC examination in breast imaging, and was Chair of the first Educational Advisory Committee for the American Institute of Radiological Pathology (AIRP). She currently heads the Screening Leadership Groups for ACR/SBI.

Dr. Monticciolo will be formally awarded with the Gold Medal Award during a ceremony to be held at the upcoming SBI/ACR Breast Imaging Symposium.


2019 Honorary Fellow

Nola Hylton, PhD, will be inducted as the newest SBI Honorary Fellow at the 2019 SBI/ACR Annual Breast Imaging Symposium. Honorary Fellow status is designated to individuals who have made outstanding contributions to breast imaging and who are otherwise eligible for membership in the society. They are elected by a majority of the Active Fellows and remain dues exempt members for life.

Dr. Hylton has been integrally involved in the development of magnetic resonance imaging for the detection, diagnosis, and staging of breast cancer. Dr. Hylton has been an internationally known leader in the field of breast MRI for more than 20 years. Her current research program focuses on the development and clinical evaluation of MRI techniques for characterizing breast cancers and assessing their response to treatment. Her laboratory collaborates closely with a multi-disciplinary team of radiologists, surgeons, oncologists, and science researchers nationwide. This is to optimize MRI techniques for the clinical management of breast cancer patients.

Dr. Hylton is among the first group of scholars named to the Susan G. Komen for the Cure’s Scientific Advisory Council. She served as co-leader for the DHHS office of Women’s Health International Working Group where she identified and addressed barriers to clinical dissemination of breast MRI. She also served as the institutional Principal Investigator of the NCI International Breast MRI Consortium, which is the first large multi-center clinical trial evaluating breast MRI for breast cancer diagnosing and staging.

Dr. Hylton has over 80 published research articles, and she has written 13 book chapters and over 130 abstracts.